074430 — Aminologics Co Cashflow Statement
0.000.00%
Last trade - 00:00
- KR₩131bn
- KR₩104bn
- KR₩21bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -1,201 | 2,140 | 5,360 | -7,282 | 2,436 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 4,053 | 471 | -639 | 15,760 | 754 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 485 | -1,070 | -4,064 | -3,603 | -3,855 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Taxes Payable | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 3,604 | 1,768 | 936 | 5,226 | -218 |
Capital Expenditures | -106 | -368 | -662 | -503 | -156 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -6,877 | -621 | 29.5 | -332 | 0 |
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -6,983 | -989 | -632 | -835 | -156 |
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -141 | -152 | -164 | -191 | -224 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -3,536 | 440 | 281 | 3,877 | -740 |